(via Beta-2 Agonist Bronchodilators - Albuterol, Salmeterol, Formoterol)

seen from Türkiye

seen from United States
seen from India

seen from Russia

seen from Germany
seen from Brazil
seen from Russia
seen from Australia
seen from Italy
seen from Indonesia
seen from Chile
seen from Netherlands
seen from United Kingdom

seen from Paraguay
seen from Türkiye
seen from Uzbekistan
seen from India
seen from Argentina
seen from Italy

seen from United States
(via Beta-2 Agonist Bronchodilators - Albuterol, Salmeterol, Formoterol)
Salmeterol - Impurity Standards - Simson Pharma
Salmeterol works by relaxing the smooth muscles in the airways, particularly in the lungs. It does this by stimulating beta2-adrenergic receptors, leading to bronchodilation (widening of the air passages) and improved airflow.
Salmeterol is used in the long-term management of asthma. It is typically prescribed for individuals with moderate to severe asthma who require additional medication alongside inhaled corticosteroids.
https://www.simsonpharma.com/promotions/salmeterol-pharmaceutical-reference-standards-impurity-standards
Lupin and Celon Pharma partner for generic version of GSK’s Advair Diskus
Lupin and Celon Pharma partner for generic version of GSK’s Advair Diskus
Vinita Gupta, 43, Group President and CEO, Lupin Pharmaceuticals and Director, Lupin
India-based drugmaker Lupin has signed an agreement with Polish biopharmaceutical firm Celon Pharma to develop a fluticasone / salmeterol dry powder inhaler (DPI).
Under the deal, Lupin will take the responsibility for commercialisation of the product, which is a generic version of GlaxoSmithKline’s (GSK)…
View On WordPress
Cipla introduces Serroflo for respiratory treatment in Germany and Sweden
Cipla introduces Serroflo for respiratory treatment in Germany and Sweden
India-based Cipla has introduced Serroflo (salmeterol/fluticasone MDI) in Germany and Sweden to treat patients suffering from asthma.
Serroflo is expected to improve the affordability of fixed combinations in Europe and help manage health costs for respiratory treatment.
Cipla Europe head Frank Pieters said: “With Serroflo, we offer in Germany and Sweden an alternative, which is…
View On WordPress